Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04790344 · ClinicalTrials.gov registry record · NA
LUX-Dx TRENDS Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System.
A NA study of Heart Failure, sponsored by Boston Scientific Corporation.
- Active
- Registry status
- NA
- Development phase
- 525
- Enrollment target
- 20
- Study locations
NCT04790344 is a NA study of Heart Failure that is active but no longer recruiting, run by Boston Scientific Corporation. The registered enrollment target is 525 participants, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (74% lower). The trial reports 20 study locations across 5 states.
The verdict
NCT04790344, a NA study of Heart Failure, is active but no longer recruiting, sponsored by Boston Scientific Corporation.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 525 participants
- Enrollment target
- 20
- Study locations
Study Summary
The primary objective of this study is to collect sensor data from insertable cardiac monitor systems.
Conditions Studied
Interventions
- DEVICE Investigational LUX-Dx ICM Implant
Study Locations (20)
California
- John Muir Medical Center - Concord
- Scripps Memorial Hospital - La Jolla
- VA Loma Linda - Loma Linda
- Kaiser Permanenty Los Angeles Medical Center - Los Angeles
- University of California - Irvine - Orange
- San Diego Cardiac Center - San Diego
- Cardiology Associates Medical Group - Ventura
Florida
- The Cardiac and Vascular Institute - Gainesville
- North Florida South Georgia VA - Gainesville
- St. John's Center for Clinical Research (First Coast Heart and Vascular Center, PLLC) - Jacksonville
- Village Heart and Vein Center - Lady Lake
- Naples Heart and Rhythm - Naples
- Sarasota Memorial Hospital - Sarasota
Georgia
- Piedmont Augusta Hospital - Augusta
- Augusta University - Augusta
- Northside Hospital - Gainesville
- Northeast Georgia Heart Center, Inc. - Gainesville
Alabama
- Grandview Medical Center - Affinity Hospital, LLC - Birmingham
- Mobile Infirmary - Mobile
Arkansas
- Arrhythmia Research Group - Jonesboro
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 525 participants |
| Start Date | 2021-03-20 |
| Est. Completion | 2026-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04790344
The ClinicalTrials.gov registry entry for NCT04790344 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 525 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (74% lower). The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Investigational LUX-Dx ICM Implant is the first listed.
NCT04790344 reports 20 study locations spanning 5 distinct geographic areas - top geographies include California, Florida, Georgia.
Frequently Asked Questions
What is clinical trial NCT04790344 about?
NCT04790344 is a clinical study titled "LUX-Dx TRENDS Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System.". The primary objective of this study is to collect sensor data from insertable cardiac monitor systems.
What is the current status of trial NCT04790344?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 525 participants. The study started on 2021-03-20. Estimated completion is 2026-06.
What conditions does trial NCT04790344 study?
This clinical trial studies the following conditions: Heart Failure.
What interventions are being tested in trial NCT04790344?
The interventions under investigation include: Investigational LUX-Dx ICM Implant (DEVICE).
Who is sponsoring clinical trial NCT04790344?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04790344 being conducted?
This trial has 20 study locations across Alabama, Arkansas, California, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.